Zeriscope

Virtually guided exposure therapy improves outcomes in patients with
PTSD

Zeriscope, Inc recently completed a 40-patient clinical trial of its Bio Ware system. The results indicated Bio Ware’s capability to transform lives. In partnership with the Medical University of South Carolina (MUSC), Bio Ware was used to allow clinicians to virtually go with the patient during the in vivo exercises, while additionally providing access to the […]

Zeriscope Awarded Grant to Innovate Exposure Therapy Treatment for PTSD

Zeriscope, Inc was awarded a Phase I SBIR Grant from National Institute of Mental Health to develop and test a wearable platform that will allow therapists to virtually accompany PTSD patients during the all-important part of therapy known as “In Vivo Exposure”. This new technology system is expected to increase patients’ willingness to attempt in […]

Reducing Stroke Risk in Kids with Sickle Cell Disease

Medical University of South Carolina stroke neurologist Robert J. Adams, M.D., knows firsthand how innovation can bring about dramatic and positive change. He was one of the STOP, Stroke Prevention Trial in Sickle Cell Anemia, investigators who found that transcranial doppler ultrasonography (TCD) could be used to assess stroke risk in children with sickle cell […]

New PTSD treatment made ‘night and day difference’ forveteran

US Veteran’s experience with Zeriscope’s Bio Ware system proves life-changing. The treatment involved 10 sessions of prolonged exposure (“PE”) therapy. Mr. Shier, a veteran who served in Afghanistan, said he started to feel better pretty quickly. “It did in 10 weeks what other treatments couldn’t do in 10 years. I’m completely off medication now, and […]